HR 2069
116th Congress
House
Health
Business records
Civil actions and liability
Corporate finance and management
Government information and archives
Health care costs and insurance
Inflation and prices
Manufacturing
Prescription drugs
SPIKE Act
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 21, 2019
Subcommittee Hearings Held.
Apr 4, 2019
Referred to the Subcommittee on Health.
Apr 3, 2019
Referred to the Subcommittee on Health.
Apr 3, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 3, 2019
Introduced in House
Plain-English summary
Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.
What's happening now
Subcommittee Hearings Held.
Committees of jurisdiction
4